RU2020122776A3 - - Google Patents

Download PDF

Info

Publication number
RU2020122776A3
RU2020122776A3 RU2020122776A RU2020122776A RU2020122776A3 RU 2020122776 A3 RU2020122776 A3 RU 2020122776A3 RU 2020122776 A RU2020122776 A RU 2020122776A RU 2020122776 A RU2020122776 A RU 2020122776A RU 2020122776 A3 RU2020122776 A3 RU 2020122776A3
Authority
RU
Russia
Application number
RU2020122776A
Other versions
RU2020122776A (ru
RU2777597C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2020122776A publication Critical patent/RU2020122776A/ru
Publication of RU2020122776A3 publication Critical patent/RU2020122776A3/ru
Application granted granted Critical
Publication of RU2777597C2 publication Critical patent/RU2777597C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/502Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU2020122776A 2018-01-09 2019-01-08 Способ получения ингибитора parp и его промежуточного соединения RU2777597C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201810019736.1 2018-01-09
CN201810019736 2018-01-09
CN201811547590 2018-12-18
CN201811547590.4 2018-12-18
PCT/CN2019/070797 WO2019137358A1 (zh) 2018-01-09 2019-01-08 一种parp抑制剂及其中间体的制备方法

Publications (3)

Publication Number Publication Date
RU2020122776A RU2020122776A (ru) 2022-01-10
RU2020122776A3 true RU2020122776A3 (ru) 2022-01-21
RU2777597C2 RU2777597C2 (ru) 2022-08-08

Family

ID=

Also Published As

Publication number Publication date
EP3738963A1 (en) 2020-11-18
KR20200108021A (ko) 2020-09-16
RU2020122776A (ru) 2022-01-10
EP3738963A4 (en) 2021-12-01
CA3085660A1 (en) 2019-07-18
AU2019207072A1 (en) 2020-07-16
US20210070760A1 (en) 2021-03-11
CN111278830B (zh) 2022-10-25
BR112020013449A2 (pt) 2020-12-01
JP2021509906A (ja) 2021-04-08
WO2019137358A1 (zh) 2019-07-18
CN111278830A (zh) 2020-06-12
US11345709B2 (en) 2022-05-31

Similar Documents

Publication Publication Date Title
BR112021012225A2 (ru)
BR122022006221A2 (ru)
BR122022015550A2 (ru)
BR112020025288A2 (ru)
BR112021008873A2 (ru)
BR122022002075A2 (ru)
AT524834A2 (ru)
AT524874A5 (ru)
AU2018438767B1 (ru)
AT521543A3 (ru)
AT524961A5 (ru)
AT524266A2 (ru)
BR122022005529A2 (ru)
BR122022016585A2 (ru)
BR212020012832U2 (ru)
BR202018071071U8 (ru)
BR102018070765A2 (ru)
BR102018016915A2 (ru)
BE2018C025I2 (ru)
BR202018008879U2 (ru)
BR202018007669U2 (ru)
BR102018007062A2 (ru)
BR202018006247U2 (ru)
BR202018004136U2 (ru)
BR202018002487U2 (ru)